Use of Genetically Modified Bacteria VPN 20009-M in the manufacture of medicines for the prevention and treatment of cancer metastasis

摘要

The present invention discloses the use of genetically engineered attenuated Salmonella typhimurium strain VNP20009-M in the manufacture of a medicament for the prevention and treatment of cancer metastasis. The genetically engineered strain VNP20009-M targets cancer cells and has a remarkable effect of inhibiting metastasis and growth. VNP20009-M can be used to prepare medicaments for the prevention and treatment of tumor metastasis.